Michael Gelband’s Smith & Wesson SWBI Stock Holding History

Michael Gelband’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-80,411	Closed	-$790K	–	2056
2025 Q3	$790K	Buy	+80,411	New	+$686K	0.01%	1041
2025 Q2	–	Sell	-58,818	Closed	-$548K	–	1954
2025 Q1	$548K	Buy	+58,818	New	+$606K	0.01%	1089
2022 Q4	–	Sell	-11,825	Closed	-$123K	–	2113
2022 Q3	$123K	Buy	+11,825	New	+$156K	﹤0.01%	1719
2022 Q1	–	Sell	-28,781	Closed	-$512K	–	2663
2021 Q4	$512K	Sell	28,781 -50,134	-64%	-$1.03M	0.01%	1382
2021 Q3	$1.64M	Buy	78,915 +31,682	+67%	+$762K	0.02%	806
2021 Q2	$1.64M	Sell	47,233 -36,978	-44%	-$774K	0.02%	771
2021 Q1	$1.47M	Buy	84,211 +15,533	+23%	+$282K	0.02%	707
2020 Q4	$1.22M	Buy	+68,678	New	+$1.14M	0.01%	758
2020 Q3	–	Sell	-81,951	Closed	-$1.36M	–	2215
2020 Q2	$1.36M	Sell	81,951 -82,406	-50%	-$766K	0.04%	592
2020 Q1	$1.05M	Buy	164,357 +28,066	+21%	+$199K	0.06%	299
2019 Q4	$972K	Buy	136,291 +66,427	+95%	+$405K	0.02%	566
2019 Q3	$314K	Buy	69,864 +702	+1%	+$4.23K	0.01%	855
2019 Q2	$479K	Buy	+69,162	New	+$490K	0.02%	492

Other funds holding SWBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Michael Gelband's SWBI Position: Q4 2025 in Review

Michael Gelband sold out of Smith & Wesson (SWBI) in Q4 2025, closing a stake of 80,411 shares — an estimated $790K sold.

Michael Gelband first reported a position in SWBI in Q2 2019 and held it in 13 quarters. The position peaked at $1.64M in Q2 2021. 169 funds tracked by Wall St. Rank hold SWBI as of Q4 2025.

Michael Gelband reported no remaining Smith & Wesson position as of Q4 2025 after selling out during the quarter.
Michael Gelband sold 80,411 Smith & Wesson shares in Q4 2025, an estimated $790K.
Michael Gelband first reported a position in Smith & Wesson in Q2 2019 and held it in 13 quarters.
Michael Gelband's Smith & Wesson position peaked at $1.64M in Q2 2021.
169 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.